Assignee
PALOBIOFARMA SL
ES·6 granted patents·1 pending application·0 citations·filing 2014–2021
Top patents by PatentIndex Score
7 records- 0156US12384754B2Cocrystals of (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acidPALOBIOFARMA SL·Filed 2021·Granted Aug 12, 2025·0 cites·20 claims
- 0254US2023321053A1(1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseasesPALOBIOFARMA SL·Filed 2021·Application pending·0 cites
- 0348US10583127B2Amine salt of (1R, 3S)-3-(5-cyano-4-phenyl-1,3- thiazol-2-ylcarbamoyl)cyclopentane carboxylic acidPALOBIOFARMA SL·Filed 2018·Granted Mar 10, 2020·0 cites·17 claims
- 0444US10744125B2Adenosine A3 receptor modulatorsPALOBIOFARMA SL·Filed 2018·Granted Aug 18, 2020·0 cites·12 claims
- 0541US10238637B2Modulators of the adenosine A3 receptorsPALOBIOFARMA SL·Filed 2016·Granted Mar 26, 2019·0 cites·14 claims
- 0641US9447095B2Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10)PALOBIOFARMA SL·Filed 2014·Granted Sep 20, 2016·0 cites·23 claims
- 0727US10253017B2Derivatives of 2-aminopyridine as adenosine A2B receptor antagonists and ligands of the melatonin MT3 receptorsPALOBIOFARMA SL·Filed 2016·Granted Apr 9, 2019·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →